The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: A prospective study

Journal of B.U.ON.

Volumn 16, Issue 1, 2011, Pages 74-79

  Spiliotis, John ^a,c   Vaxevanidou, A ^b   Sergouniotis, F ^c   Lambropoulou, E ^d   Datsis, A ^c   Christopoulou, A ^e  

^a METAXA CANCER HOSPITAL   (Greece)

^b Gennimatas General Hospital   (Greece)

^c Mesolonghi General Hospital   (Greece)

^d General Hospital of Messolonghi   (Greece)

^e UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

Author keywords

Cytoreduction; HIPEC; Ovarian cancer

Indexed keywords

CISPLATIN; DOXORUBICIN;

ABDOMINAL ABSCESS; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DRUG ERUPTION; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTHERMIC INTRAOPERATIVE CHEMOTHERAPY; ILEUS; INTESTINE FISTULA; LUNG EMBOLISM; MORBIDITY; MULTIPLE ORGAN FAILURE; OVARY CANCER; OVERALL SURVIVAL; PLEURA EFFUSION; PROSPECTIVE STUDY; SURGICAL DRAINAGE; SURVIVAL RATE; URINARY TRACT FISTULA; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES;

EID: 79954452213     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience. Eur J Surg Oncol 2009; Apr 7 (Epub ahead of print).
2. Helm CW, Bristow RE, Kusamura S, Baratti D, Deraco M. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 2008; 98: 283-290.
3. Corte E, Glehen O, Mohamed F et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: Prospective study of 81 patients. World J Surg 2007; 31: 1813-1820. (Pubitemid 47283201)
4. Vasey PA. Resistance to Chemotherapy in Advanced Ovarian Cancer: Mechanisms and Current Strategies. Br J Cancer 2003; 89 Suppl 3: S23-S28. (Pubitemid 38068000)
5. Fagotti A, Paris I, Grimolizzi F et al. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum- sensitive recurrent ovarian cancer patients: A pilot study. Gynecol Oncol 2009; 113: 335-340.
6. Spiliotis J, Rogdakis A, Vaxevanidou A, Datsis A, Zacharis G, Christopoulou A. Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. J BUON 2009; 14: 259-264.
7. Sugarbaker PH. Management of Peritoneal-Surface Malignancy: the Surgeon's Role. Langenbecks Arch Surg 1999; 384: 576-587. (Pubitemid 30020346)
8. Sugarbaker PH. Peritonectomy Procedures. Cancer Treat Res 2007; 134: 247-264.
9. Armstrong DK, Bundy B, Wenzel L et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354: 3443.
10. Cannistra SA. Cancer of the Ovary. N Engl J Med 2004; 351: 2519-2529.
11. de Bree E, Rosing H, Michalakis J et al. Intraperitoneal Chemotherapy With Taxanes for Ovarian Cancer With Peritoneal Dissemination. Eur J Surg Oncol 2006; 32: 666-670. (Pubitemid 44087882)
12. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20: 1248-1259. (Pubitemid 34177431)
13. de Gramont A, Drolet Y, Varette C et al. Survival After Second-Look Laparotomy in Advanced Ovarian Epithelial Cancer. Study of 86 Patients. Eur J Cancer Clin Oncol 1989; 25: 451-457. (Pubitemid 19061765)
14. Morgan RJ Jr, Alvarez RD, Armstrong DK et al. Ovarian Cancer. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2006; 4: 912-939. (Pubitemid 44580192)
15. Reichman TW, Cracchiolo B, Sama J et al. Cytoreductive Surgery and Intraoperative Hyperthermic Chemoperfusion for Advanced Ovarian Carcinoma. J Surg Oncol 2005; 90: 51-56. (Pubitemid 40594099)
16. Raspagliesi F, Kusamura S, Campos Torres JC et al. Cytoreduction Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy in Advanced/Recurrent Ovarian Cancer Patients: The Experience ofNational Cancer Institute of Milan. Eur J Surg Oncol 2006; 32: 671-675. (Pubitemid 44063998)
17. Yen MS, Juang CM, Lai CR, Chao GC, Ng HT, Yuan CC. Intraperitoneal Cisplatin-Based Chemotherapy Vs. Intravenous Cisplatin-Based Chemotherapy for Stage III Optimally Cytoreduced Epithelial Ovarian Cancer. Int J Gynaecol Obstet 2001; 72: 55-60.
18. Alberts DS, Liu PY, Hannigan EV et al. Intraperitoneal Cisplatin Plus Intravenous Cyclophosphamide Versus Intravenous Cisplatin Plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer. N Engl J Med 1996; 335: 1950-1955. (Pubitemid 26428219)
19. Zanon C, Clara R, Chiappino I et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 2004; 28: 1040-1045. (Pubitemid 40109891)
20. Rufian S, Munoz-Casares FC, Briceno J et al. Radical surgery- peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. J Surg Oncol 2006; 94: 316-324. (Pubitemid 44330855)
21. Ceelen WP, Van Nieuwenhove Y, Van Belle S et al. Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion in Women with Heavily Pretreated Recurrent Ovarian Cancer. Ann Surg Oncol 2009, Dec 2009 [Epub ahead of print].